Nexien BioPharma, Inc. (OTCMKTS:NXEN) Short Interest Up 28,800.0% in April

Nexien BioPharma, Inc. (OTCMKTS:NXEN) was the target of a significant increase in short interest in April. As of April 15th, there was short interest totalling 28,900 shares, an increase of 28,800.0% from the March 31st total of 100 shares. Based on an average trading volume of 22,100 shares, the days-to-cover ratio is presently 1.3 days.

Nexien BioPharma Stock Performance

OTCMKTS:NXEN opened at $0.02 on Friday. Nexien BioPharma has a one year low of $0.01 and a one year high of $0.10. The business’s 50-day simple moving average is $0.02 and its 200 day simple moving average is $0.02. The stock has a market cap of $1.37 million, a price-to-earnings ratio of -2.03 and a beta of 1.60.

Nexien BioPharma Company Profile

Nexien BioPharma, Inc focuses on the formulation, development, and commercialization of cannabinoid-based pharmaceuticals, drug delivery systems, and related technologies for diseases, disorders, and medical conditions. The company was formerly known as Intiva BioPharma Inc and changed its name to Nexien BioPharma, Inc in September 2018.